Click a keyword to view all the abstracts on this site tagged with that keyword.
- therapeutic management
- therapeutic targeting
- therapeutic targeting and Cell Signaling
- therapeutic targeting and tissue remodeling
- therapeutic targeting and tolerance
- therapeutic targeting and toll-like receptors
- therapeutic targeting and treatment
- therapeutic targeting and treatment options
- therapeutic targeting and tumor necrosis factor (TNF)
- therapeutic targeting and uric acid
- therapeutic targeting and vaccines
- therapy
- therapy and fibrosis
- therapy and immunoregulation
- therapy and rheumatic disease
- therapy and tocilizumab
- therapy and toll-like receptors
- therapy and treatment
- therapy and tumor necrosis factor (TNF)
- therapy and ultrasonography
- therapy and uveitis
- therapy and vaccination
- therapy and vasculitis
- Therapy, alternative
- Therapy, complementary
- thermal analysis
- thermography and ultrasound
- three-material decomposition
- thrombocytopenia
- thrombocytopenia and idiopathic thrombocytopenic purpura - ITP
- thrombocytopenia and thrombosis
- Thrombosis
- thrombosis and Co-morbidities
- thrombosis and connective tissue diseases
- thrombosis and drug safety
- thrombosis and international
- thrombosis and Lupus
- thrombosis and prognostic factors
- thrombosis and race
- thrombosis and risk factor
- thrombosis and treatment
- thrombosis and ultrasound
- thrombosis and vasculitis
- thrombosis and vessel vasculitis
- thymectomy
- thyroid
- thyroid and anemia
- thyroid cancer and incidence
- thyroperoxidase and antinuclear antibodies (ANA)
- tie
- Tildrakizumab
- time management and ultrasonography
- Timed Function tests
- tissue
- Tissue Engineering
- tissue growth factor (TGF)
- tissue growth factor (TGF) and fibroblasts
- tissue remodeling and tumor necrosis factor (TNF)
- titer
- TLR4
- TLR7
- TMJ
- TNF-blocking Antibody
- TNF-α blockers and Drug efficacy
- TNFi and methotrexate (MTX)
- TNFi and registries
- TNFSF13 and migration inhibitory factor (MIF)
- tobacco use
- tobacco use and health disparities
- tobacco use and rheumatoid arthritis (RA)
- tobacco use and tofacitnib
- tobacco use and total joint replacement
- tobacco use and uveitis
- tobacco use and vasculitis
- Tocilizumab
- tocilizumab and bioinformatics
- tocilizumab and Biologics
- tocilizumab and CLINICAL MANIFESTATIONS
- tocilizumab and Disease Activity
- tocilizumab and efficacy
- tocilizumab and giant cell arteritis
- tocilizumab and glucocorticoids
- tocilizumab and large vessel vasculitis
- tocilizumab and lipids
- tocilizumab and methotrexate (MTX)
- tocilizumab and prednisolone
- tocilizumab and quality of life
- tocilizumab and rheumatoid arthritis
- tocilizumab and rituximab
- tocilizumab and safety
- tocilizumab and tofacitinib
- tocilizumab and tofacitnib
- tocilizumab and tolerance
- tocilizumab and treatment
- tocilizumab and treatment options
- tocilizumab and tumor necrosis factor (TNF)
- tocilizumab and ultrasound
- tocilizumab and uveitis
- tocilizumab and vaccines
- tocilizumab and vasculitis
- tocilizumab and viruses
- Tofacitinib
- tofacitinib and baricitinib
- tofacitinib and cognitive dysfunction
- tofacitinib and IL-17
- tofacitinib and Janus kinase (JAK)
- tofacitinib and lipids
- tofacitinib and Reproductive Health
- tofacitinib and salivary gland
- tofacitinib and tofacitinib
- tofacitinib and treatment
- tofacitinib and treatment options
- tofacitinib and tumor necrosis factor (TNF)
- tofacitinib and ultrasound
- Tofacitinib and vaccines
- tofacitinib and viruses
- tofacitinib and work
- tofacitnib and tumor necrosis factor (TNF)
- tofacitnib and work
- tolerance
- tolerance and toll-like receptors
- tolerance and treatment
- tolerance and vasculitis
- tolerance and viruses
- Toll Like receptors
- toll-like receptors and innate immunity
- toll-like receptors and interferons
- toll-like receptors and transcriptional regulation
- toll-like receptors and treatment
- toll-like receptors and tumor necrosis factor (TNF)
- toll-like receptors and vasculitis
- toll-like receptors and viruses
- tophaceous gout
- tophaceous gout and tophi
- Tophaceous gout and ultrasound
- tophaceous gout and urate
- tophaceous gout and uric acid
- topoisomerase
- Total Hip Arthroplasty
- Total joint replacement
- Total Knee Arthroplasty
- Total Knee Arthroplasty (TKA)
- Total Knee Arthroplasty (TKA) and anticoagulation
- Total Knee Arthroplasty (TKA) and decision analysis
- Total Knee Arthroplasty (TKA) and non-pharmacologic intervention
- Total Knee Arthroplasty (TKA) and outcome measures
- Total Knee Arthroplasty (TKA) and pain management
- Total Knee Arthroplasty (TKA) and physical activity
- Total Knee Arthroplasty (TKA) and psychosocial factors
- Total Knee Arthroplasty (TKA) and rheumatoid arthritis (RA)
- Tph and Synovial Immune Biology
- trabecular bone score
- tracer
- TRACTISS
- trainee
- trainee and ultrasonography
- trainee and ultrasound
- transcription factor
- transcription factor and gout
- transcription factor and transcriptional regulation
- transcription factor and transforming growth factor
- transcription factor and tumor necrosis factor (TNF)
- transcription factor and tumor suppressors
- transcription factor and wounds
- transcriptional regulation
- transcriptional regulation and tumor necrosis factor (TNF)
- transcriptome
- Transcriptomic
- transcriptomics
- Transforming Growth Factor (TGF)
- transforming growth factor and exosome
- transforming growth factor and treatment
- transforming growth factor and tyrosine kinase inhibition
- transglutaminase-2 and myositis
- transient elastography
- Transition
- Transition and doctor-patient relationship
- Transition and health literacy
- Transition and longitudinal studies
- Transition and pediatric rheumatology
- Transition and pediatrics
- Transition and serologic tests
- Transition and systemic lupus erythematosus (SLE)
- Transition and young adults
- transplant
- transplantation
- transplantation and complications
- transplantation and renal disease
- transplantation and treatment
- transplantation and vasculitis
- transplantation and vasculogenesis
- Traps
- Traps and canakinumab
- Traps and genetic disorders
- Traps and mitochondria
- Trauma
- treat to target
- treatment
- treatment and Biologic agents
- treatment and biologic drugs